| # of Vials | Price (AUD) |
|---|---|
| 1 | $89.95 |
| 2 | $169.95 (5% Discount) |
| 3 | $249.95 (10% Discount) |
| 4 | $319.95 (15% Discount) |
| 5 | $349.95 (20% Discount) |
Retatrutide is a Triple-Agonist peptide compound of significant interest in metabolic research.It functions by targeting three distinct hormonal pathways simultaneously. This results in a more comprehensive approach to metabolic regulation and weight management than previously possible with single or dual-action peptides.
The "Triple Agonism" effect is achieved by stimulating three key receptors:
Your AMANA Therapeutics Research Kit is a complete, pharmaceutical-grade solution:
| Feature | AMANA Therapeutics | Standard Sellers |
|---|---|---|
| 3rd Party Lab Verified | ✅ >99.8% Pure | ❓ Unverified |
| Endotoxin Screened | ✅ Yes | ❌ None |
| 1-on-1 Hands-On Support | ✅ Unlimited | ❌ Generic |
| Shipping Location | 🇦🇺 Australian Stock | 🚢 Overseas |
| HPLC LCMS Validated | ✅ Every Time | ❓ Unknown |
Yes. All stock is held in Australia for quick shipping, depending on the state shipping can be expected between 1-3 days.
If our FAQ page don't answer your questions, please feel free to contact us via email or WhatsApp
AMANA Therapeutics products are intended for research and laboratory use only. Our compounds are not approved for human consumption and should not be used except by qualified researchers in appropriate institutional settings with proper regulatory approval (including IRB/ethics board approval where required). Users are solely responsible for ensuring compliance with all applicable laws and regulations in their jurisdiction.